Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated Jan 30, 2023 (4 years ago)

Artificial Tears

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Non-Sterility: FDA analysis found unopened products to have bacterial contamination.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.

Affected NDC 79503-0101-15

Compare with the code on your package — it is the most precise check available.

Category: Eye Drops & Ophthalmic

Recalling firm
Global Pharma Healthcare Private Limited
NDC code
79503-0101-15
Origin
N/A, India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0919-2023 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other recalls by Global Pharma Healthcare Private Limited

All 2023 recalls
Class II · Moderate risk

Delsam Pharma's ARTIFICIAL TEARS

CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.

Ongoing cGMP deviation Global Pharma Healthcare Private Limited D-0922-2023
Class II · Moderate risk

Artificial Tears

CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.

Ongoing cGMP deviation Global Pharma Healthcare Private Limited NDC 79503-0101-15 D-0920-2023

Other sterility / contamination recalls from 2023

All sterility / contamination recalls